Aurus Bios invests exclusively in Healthcare companies, focusing on early stage companies, with an attractive business potential and scalable technologies that address global challenges.
Our portfolio of companies includes early stage developments, with successful preclinical studies and Clinical Phases under development, new therapeutic targets and approaches for treatment of unattended conditions, using disruptive technologies.
We invest in companies developing products in specialty therapeutic areas where there are diseases and conditions with no treatment yet, or where the available treatments are not effective and /or safe enough, creating a market opportunity.
Medical technologies and diagnostics are the backbone of almost all medical decisions. We invest in companies developing medical devices and technologies that allow safer, quicker and more effective interventions.